Taken together, SCG3 expression was significantly higher in IDH-mutant/1p19q-codeleted gliomas than the other subtypes of glioma, and SCG3 transcriptional activity was decreased in the mesenchymal subtype of GBMs. Here, SCG3 is linked to central nervous system cancer.